Company Overview

Company name: Folium Biosciences
Description: Operator of an end to end seed to wholesale company intended to provide medicinal hemp and hemp-derived spectrum products. The company’s products are derived from industrial hemp that isolates and removes any unwanted compounds while creating the maximum potency level of phytocannabinoids, enabling clients to receive hemp oil that can then be used for a multitude of consumer product applications.
Year founded: 2014
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.foliumbiosciences.com
Employees:
City: Colorado Springs
State: Colorado
Country: United States
Region:

Financial Highlights

Start up capital raised (USD Million): 3.00
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company reached a definitive agreement to acquire Australis Capital through a reverse merger on December 11, 2019. Subsequently the deal was cancelled.
Number of active investors:
Profile last updated: 27-Mar-2020
Last known valuation:
Last known valuation date: